Proof of concept of physiologically based pharmacokinetic modelling in paediatric acute lymphoblastic leukaemia
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19410 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Thomas Bauch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute for Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Asparaginase, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Physiologically based pharmacokinetic (PBPK) modelling is an alternative modelling technique that is increasingly used in pharmacokinetics. Due to its nature, it can be complementarily employed to population pharmacokinetics, especially when it comes to small population size. Here, we report the proof of concept of its application to accurately describe the pharmacokinetics of a recombinant L‐asparaginase in paediatric patients with acute lymphoblastic leukaemia. Data from two randomized, double‐blind, phase II/III clinical studies (MC‐ASP.4/ALL; MC‐ASP.5/ALL) were included to setup and evaluate the final model, respectively. Final population values for basic pharmacokinetic parameters were calculated (clearance: 0.0569 L/h/19.5 kg, volume of distribution: 1.251 L, half‐life: 18.5 h, trough concentration: 140.9 IU/L). Pharmacokinetic parameter prediction as well as predictive performance of the model proofed to be comparable to a separately developed population pharmacokinetic model with 13% deviation in predicted median L‐asparaginase trough levels. To the best of our knowledge, this is the first whole‐body PBPK model of a non‐antibody therapeutic protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Institute for Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany.
ORCID-Profile: Thomas Bauch, Georg Hempel
Zitieren
APA
Bauch, T., & Hempel, G. (2024). Proof of concept of physiologically based pharmacokinetic modelling in paediatric acute lymphoblastic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.19410
Vancouver
Bauch T, Hempel G. Proof of concept of physiologically based pharmacokinetic modelling in paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 2024. doi:10.1111/bjh.19410
BibTeX
@article{Bauch2024,
author = {Bauch, Thomas and Hempel, Georg},
title = {Proof of concept of physiologically based pharmacokinetic modelling in paediatric acute lymphoblastic leukaemia},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19410}
}
EUVIMED